Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Initiation and Maintenance Disorders | 18 | 2022 | 90 | 4.650 |
Why?
|
| Sleep Wake Disorders | 7 | 2024 | 167 | 2.130 |
Why?
|
| Sleep | 16 | 2024 | 343 | 2.120 |
Why?
|
| Menopause | 6 | 2019 | 75 | 1.380 |
Why?
|
| Pregnancy Complications | 3 | 2022 | 512 | 1.020 |
Why?
|
| Women's Health | 4 | 2019 | 133 | 0.860 |
Why?
|
| Restless Legs Syndrome | 1 | 2022 | 16 | 0.780 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2023 | 205 | 0.780 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2022 | 74 | 0.730 |
Why?
|
| Mood Disorders | 1 | 2019 | 122 | 0.600 |
Why?
|
| Premature Birth | 1 | 2022 | 385 | 0.580 |
Why?
|
| Postpartum Period | 1 | 2019 | 214 | 0.560 |
Why?
|
| Pain | 1 | 2020 | 461 | 0.560 |
Why?
|
| Actigraphy | 3 | 2024 | 45 | 0.540 |
Why?
|
| Menstrual Cycle | 3 | 2024 | 34 | 0.540 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 196 | 0.530 |
Why?
|
| Interleukin-6 | 1 | 2018 | 419 | 0.510 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 872 | 0.440 |
Why?
|
| Inflammation | 1 | 2018 | 1431 | 0.350 |
Why?
|
| Sleep Medicine Specialty | 2 | 2020 | 6 | 0.310 |
Why?
|
| Circadian Rhythm | 4 | 2019 | 270 | 0.300 |
Why?
|
| Emotions | 2 | 2024 | 352 | 0.280 |
Why?
|
| Polysomnography | 5 | 2024 | 146 | 0.270 |
Why?
|
| Melatonin | 3 | 2013 | 25 | 0.270 |
Why?
|
| Female | 23 | 2024 | 66570 | 0.260 |
Why?
|
| Postmenopause | 2 | 2017 | 126 | 0.250 |
Why?
|
| Adult | 14 | 2024 | 29489 | 0.220 |
Why?
|
| Humans | 30 | 2024 | 124728 | 0.220 |
Why?
|
| Natural Language Processing | 1 | 2024 | 63 | 0.210 |
Why?
|
| Sleep Apnea, Central | 1 | 2023 | 9 | 0.210 |
Why?
|
| Stroke Rehabilitation | 1 | 2023 | 59 | 0.200 |
Why?
|
| Middle Aged | 15 | 2024 | 26797 | 0.190 |
Why?
|
| Menstruation | 1 | 2021 | 29 | 0.190 |
Why?
|
| Self-Management | 1 | 2023 | 100 | 0.180 |
Why?
|
| Machine Learning | 1 | 2024 | 250 | 0.180 |
Why?
|
| Cognition | 3 | 2021 | 722 | 0.180 |
Why?
|
| Social Media | 1 | 2022 | 105 | 0.180 |
Why?
|
| Dreams | 1 | 2020 | 24 | 0.170 |
Why?
|
| Body Mass Index | 3 | 2018 | 1563 | 0.170 |
Why?
|
| Advisory Committees | 1 | 2020 | 153 | 0.160 |
Why?
|
| Pregnancy | 3 | 2022 | 7178 | 0.160 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 588 | 0.160 |
Why?
|
| Cesarean Section | 1 | 2022 | 387 | 0.160 |
Why?
|
| Behavior Therapy | 1 | 2021 | 254 | 0.150 |
Why?
|
| Ovariectomy | 1 | 2019 | 181 | 0.150 |
Why?
|
| Berlin | 1 | 2018 | 3 | 0.150 |
Why?
|
| Hot Flashes | 1 | 2018 | 6 | 0.150 |
Why?
|
| Depression | 4 | 2021 | 1224 | 0.150 |
Why?
|
| Orgasm | 1 | 2017 | 7 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 596 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2024 | 723 | 0.140 |
Why?
|
| Behavioral Medicine | 1 | 2016 | 10 | 0.130 |
Why?
|
| Depressive Disorder | 2 | 2011 | 450 | 0.130 |
Why?
|
| Dementia | 1 | 2021 | 452 | 0.130 |
Why?
|
| Geographic Mapping | 1 | 2016 | 14 | 0.130 |
Why?
|
| Pandemics | 2 | 2022 | 1102 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2020 | 1391 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2020 | 693 | 0.130 |
Why?
|
| Medically Underserved Area | 1 | 2016 | 90 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 428 | 0.120 |
Why?
|
| Sexual Behavior | 1 | 2017 | 245 | 0.120 |
Why?
|
| Intimate Partner Violence | 1 | 2015 | 25 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 986 | 0.120 |
Why?
|
| Affective Symptoms | 1 | 2015 | 59 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 569 | 0.110 |
Why?
|
| Phenotype | 1 | 2024 | 4255 | 0.110 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 3716 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2018 | 635 | 0.100 |
Why?
|
| Hydrocortisone | 1 | 2013 | 217 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2018 | 1352 | 0.100 |
Why?
|
| Mental Health | 1 | 2015 | 344 | 0.100 |
Why?
|
| Young Adult | 6 | 2024 | 9024 | 0.100 |
Why?
|
| Seasons | 1 | 2013 | 310 | 0.100 |
Why?
|
| Aged | 7 | 2024 | 19764 | 0.090 |
Why?
|
| Veterans | 1 | 2023 | 1757 | 0.090 |
Why?
|
| Neoplasms | 2 | 2024 | 2788 | 0.090 |
Why?
|
| Heart Failure | 1 | 2023 | 2285 | 0.080 |
Why?
|
| Progesterone | 2 | 2009 | 623 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8191 | 0.080 |
Why?
|
| Biomarkers | 1 | 2018 | 3067 | 0.080 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2009 | 44 | 0.080 |
Why?
|
| Affect | 2 | 2024 | 158 | 0.080 |
Why?
|
| Comorbidity | 2 | 2024 | 1532 | 0.080 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2007 | 186 | 0.070 |
Why?
|
| Estrogens | 1 | 2009 | 504 | 0.070 |
Why?
|
| Male | 10 | 2024 | 61270 | 0.070 |
Why?
|
| Sexual Partners | 2 | 2017 | 87 | 0.060 |
Why?
|
| Unsupervised Machine Learning | 1 | 2024 | 12 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2012 | 806 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 924 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2004 | 66 | 0.050 |
Why?
|
| Logistic Models | 2 | 2019 | 1812 | 0.050 |
Why?
|
| Quality of Life | 2 | 2024 | 1935 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2007 | 553 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2024 | 399 | 0.050 |
Why?
|
| Hemiplegia | 1 | 2023 | 45 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 157 | 0.050 |
Why?
|
| Adolescent | 4 | 2024 | 19287 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 156 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1328 | 0.040 |
Why?
|
| Fatigue | 1 | 2021 | 189 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 16335 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 2895 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 352 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2024 | 4806 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 129 | 0.040 |
Why?
|
| Medicare | 1 | 2023 | 424 | 0.040 |
Why?
|
| Survivors | 1 | 2021 | 335 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2021 | 12357 | 0.040 |
Why?
|
| Age Factors | 1 | 2024 | 2820 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 3432 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 196 | 0.030 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2017 | 79 | 0.030 |
Why?
|
| Cities | 1 | 2016 | 47 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2017 | 73 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1110 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 505 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2020 | 555 | 0.030 |
Why?
|
| United States | 2 | 2023 | 10899 | 0.030 |
Why?
|
| Darkness | 1 | 2013 | 27 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 1659 | 0.030 |
Why?
|
| Periodicity | 1 | 2013 | 55 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1269 | 0.030 |
Why?
|
| Light | 1 | 2013 | 174 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 319 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 6308 | 0.020 |
Why?
|
| Child | 2 | 2021 | 24386 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 256 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 215 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1016 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 472 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 475 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6147 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2007 | 131 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 92 | 0.020 |
Why?
|
| Reaction Time | 1 | 2007 | 175 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 182 | 0.020 |
Why?
|
| Perception | 1 | 2007 | 219 | 0.020 |
Why?
|
| Estradiol | 1 | 2007 | 531 | 0.020 |
Why?
|
| Memory | 1 | 2007 | 361 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5161 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 3447 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 10286 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 6548 | 0.010 |
Why?
|